Lipoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Lipoma}} | {{Lipoma}} | ||
{{ | {{CMG}} {{AE}} {{Sahar}} | ||
==Overview== | |||
There are no established measures for the [[secondary prevention]] of lipoma. | |||
==Secondary Prevention== | |||
There are no established measures for the [[secondary prevention]] of lipoma. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 8: | Line 12: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category: | [[Category:Endocrinology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Needs content]] | |||
[[Category:Needs overview]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Latest revision as of 17:19, 22 November 2019
|
Lipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lipoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lipoma secondary prevention |
|
Risk calculators and risk factors for Lipoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
There are no established measures for the secondary prevention of lipoma.
Secondary Prevention
There are no established measures for the secondary prevention of lipoma.